Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-17
1995-09-26
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
054534364
ABSTRACT:
A new use of, and method of treatment of atherosclerosis using, a compound selected from the group consisting essentially of compounds of Formula I: ##STR1## wherein: R.sub.1 is hydrogen, lower alkanoyl of up to 6 carbon atoms or aroyl selected from benzoyl and naphthoyl;
REFERENCES:
patent: 4503067 (1985-03-01), Wiedemann et al.
Stedman's Medical Dictionary, Twenty-second Edition, Williams & Wilkins Co., Baltimore, Md., (1972) p. 123.
Boehringer Mannheim Pharmaceutical Corporation
Cintins Marianne M.
Criares T. J.
Lentz Edward T.
SmithKline Beecham Corp.
LandOfFree
Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanola does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanola, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanola will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1552045